MedPath

The Effect of Natrox® Oxygen Wound Therapy on the Healing Rate of Chronic Diabetic Foot Ulcers

Not Applicable
Completed
Conditions
Diabetic Foot Ulcer
Surgical Wound
Registration Number
NCT03905863
Lead Sponsor
Inotec AMD Limited
Brief Summary

A Multicentre Randomized Controlled Trial to Investigate the Effect of Natrox Topical Oxygen Wound Therapy on the Healing rates of Diabetic Foot Ulcers.

Detailed Description

Patients with diabetic foot ulcers will be enrolled into the trial at multiple wound care centers and hospital research centers across the United States of America. After qualifying per protocol, patients will be randomized to receive standard wound care or standard wound care plus Topical Oxygen Wound Therapy for their wounds. Patients will be monitored for 12 weeks. The primary comparator between the groups will be complete wound healing at 12 weeks, but other parameters will be assessed, such as pain, wound size reduction and infection status.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
145
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Participants That Achieve Complete Wound Closure During the Twelve Week Study and the Percentage Change in Participant Ulcer Size at 12 Weeks From Baseline.Twelve (12) weeks from Time 0

Photographic wound evaluation and measurements were conducted utilizing an AI-driven computerized planimetry imaging system (Tissue Analytics, Inc., Baltimore, MD USA).15 This system obtained both 2D and 3D assessments of the wound at each visit through a standardized mobile device; in addition, the lead investigator reviewed all digital images.

Percentage Reduction in Ulcer Area (cm^2).Twelve (12) weeks from Time 0

Wound size change over time using a wound imaging measurement system. Percentage change in ulcer area was calculated on the basis of area change from the start of the study to the final recorded value. Any healed ulcer was recorded as having achieved 100% reduction in area; positive values indicate a reduction in size over the 12-week period while negative values indicate that the ulcer increased in size.

Secondary Outcome Measures
NameTimeMethod
Level of Pain of the WoundUp to twelve (12) weeks from Time 0

Does pain associated with the wound change over time using a Visual Analogue Scale Pain intensity of the reference DFU is to be assessed before any dressing changes or other ulcer manipulations at all screening and treatment visits.

Subject will be asked to indicate a numerical value that best represents the pain intensity at ulcer site on a scale of 0 to 10 anchored by word descriptors at each end, as "no pain" on the left side and "worst possible pain" on the right side of the number line. The number 0 represent "no pain", the number 5 represents "moderate pain" and the number 10 represents the "worst possible pain". The subject indicates the level of pain intensity by selecting a number on the line that represents their perception of their current state.

Number of Adverse EventsUp to twelve (12) weeks from time 0

Number of adverse events, such as infections, that are found associated with the study wound

Trial Locations

Locations (20)

New Hope Podiatry Clinic

🇺🇸

Los Angeles, California, United States

San Marcus Research Clinic

🇺🇸

Miami Lakes, Florida, United States

Global Health Research Center Inc

🇺🇸

Miami Lakes, Florida, United States

MedCare Research

🇺🇸

Miami, Florida, United States

Barry University Clinical Research

🇺🇸

North Miami Beach, Florida, United States

Royal Research Corp

🇺🇸

Pembroke Pines, Florida, United States

Doctors Research Network

🇺🇸

South Miami, Florida, United States

Pharma Research Associates

🇺🇸

Westchester, Florida, United States

Wahab Consulting and Research

🇺🇸

Las Vegas, Nevada, United States

Cleveland Foot and Ankle Clinic

🇺🇸

Cleveland, Ohio, United States

Scroll for more (10 remaining)
New Hope Podiatry Clinic
🇺🇸Los Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.